PharmTech Drug Digest 11.20
|Articles|January 2, 2004

Pharmaceutical Technology

  • Pharmaceutical Technology-01-02-2004
  • Volume 28
  • Issue 1

The Bioterrorism Act

Two FDA final rules issued in response to the Bioterrorism Response Act of 2002 may significantly affect the supply and importation of pharmaceutical excipients.

Articles in this issue

almost 23 years ago

Manufacturing Execution Systems

almost 23 years ago

State-of-the-Art Packaging Machines

almost 23 years ago

January 2004

almost 23 years ago

New Supply-Chain Dynamics

almost 23 years ago

In the Spotlight--February 2004

almost 23 years ago

January 2004

Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.